Skip to main content

An Update from IRMC on the COVID-19 Vaccine: March 17, 2021

An Update from IRMC on the COVID-19 Vaccine: March 17, 2021

Wednesday, March 17, 2021

Over the past few months, IRMC has administered over 12,000 vaccines to the most at risk groups in our community, as well as frontline healthcare workers. At this time, we are proud to report that we are now able to expand our criteria to vaccinate even more of our population.

How can I get the vaccine?
As of today, March 17, 2021, we are now able to offer the Pfizer-BioNTech vaccine to individuals age 55 or older with a health condition defined by the PA Department of Health, putting an individual into the Phase1A category, and healthcare workers.

  • If you completed the form on our website previously, all you need to do now is remain patient and answer the phone when we call, as we will open up additional vaccine clinic appointments as supply is received.
  • If you meet the criteria, and have not previously signed up, you may complete the interest form to be placed on a waiting list for when more clinic dates are scheduled.
  • You do not need to complete the form more than once and walk-ins at our clinics will not be accepted.

Vaccine Interest Form

What else can I do?
It’s key that you continue following safety guidelines, including wearing a face mask that covers your mouth and nose, social distancing, and washing your hands frequently. These guidelines still apply even after you receive the vaccine.

We encourage you to receive the vaccine if it becomes available in your area, and be sure you receive your second dose at the same location.

On the horizon
As you may be aware, the Food and Drug Administration issued emergency use authorization for a third COVID-19 vaccine, Johnson & Johnson (Janssen). While both the Pfizer-BioNTech and Moderna vaccines require two doses, the Johnson & Johnson vaccine is currently a one-dose vaccine. We are excited by this news and are working with officials to hopefully provide this vaccine as supplies are made available to us.